Gilead, the drug's maker, is now testing Obeldesivir in Phase 2 trials for the Marburg virus, a close relative of Ebola. Geisbert also stressed the importance of US government funding for such ...

A petition has been launched urging the U.S. Food and Drug Administration to fast-track a new Ebola drug There is currently no cure or vaccine for the deadly disease But a clinical trial for ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

New cases of Ebola in West Africa have been dropping steadily since the peak of the crisis last fall, but details about human trials of the drugs designed to fight the crisis are still rolling in.

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space. Jef Akst was managing editor of The Scientist, ...

Although we're still a long way from a cure, here are four of the antiviral drugs scientists are looking at right now. One short-term solution could be an anti-Ebola drug called remdesivir.

Jeanne Whalen writes about the U.S. economy from the Chicago bureau. She previously covered healthcare, general news and ...

A comprehensive FAQ section answers questions for common drugs, giving you a deeper understanding of how these medications work to alleviate Ebola Virus Disease symptoms.

More than 40 years after it was identified, the Ebola virus continues to defy drugs, treatment plans—and experts’ best efforts to solve its mysteries. Ebola vaccine has to be kept cold.

Please log in, or sign up for a new account and purchase a subscription to continue reading. BEST VALUE! Like never before, the Daily News delivers real value every ...